Clinical trial Recruiting at 1 site Observational Ages 18 to 80

RNA sequencing of removed tracheal tissue to characterize scarring in tracheal and subglottic stenosis

Official title: RNA Sequencing of Discarded Tracheal Stenosis Tissue to Characterize Cellular and Molecular Pathogenesis

Run by University of Maryland, Baltimore · NCT07258784 · Data updated 2026-11-12

This project will test whether RNA sequencing of tissue removed from people with benign tracheal or subglottic stenosis can reveal molecular patterns that explain the scarring.

More Tracheal Stenosis trials

Quick facts

Study typeObservational
Ages18 Years to 80 Years
SexAll
Enrollment10 (estimated)
SponsorUniversity of Maryland, Baltimore
Academic / other
Locations1 site (Baltimore, Maryland)
StatusRecruiting
StartedSeptember 11, 2025
Main results expectedSeptember 10, 2026
Study endsDecember 31, 2026
Registry record updatedDecember 2, 2025
Trial IDNCT07258784 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people with benign tracheal or subglottic stenosis who are undergoing biopsy or surgical resection and do not have active infection or cancer.

Probably not a fit

Patients with malignant airway disease, active infections, or those not scheduled for tissue biopsy or resection are not eligible and would not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational project collects tissue that would otherwise be discarded during routine biopsies or surgical resections in patients with benign tracheal or subglottic stenosis. Researchers will perform RNA sequencing to profile gene expression and define disease-specific molecular signatures. Patients with malignancy or active infection are excluded, and clinical care is not altered by participation. The aim is to map cellular and inflammatory pathways involved in fibroinflammatory airway narrowing to inform future diagnostics and therapies.

Why it matters

Potential benefit: If successful, the findings could identify biomarkers or molecular targets that lead to improved diagnosis or new treatments for benign tracheal stenosis.

How similar studies have gone: RNA sequencing has successfully revealed disease mechanisms in other fibrotic and inflammatory airway conditions, but applying it specifically to benign tracheal stenosis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients with benign tracheal stenosis

Exclusion Criteria:

* Malignancy. active infection

Where it's running

  • University of Maryland
    Baltimore, Maryland, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.